Literature DB >> 10409404

Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism.

S E Murphy1, L M Johnson, D A Pullo.   

Abstract

The primary metabolite of nicotine in smokers is cotinine. Cotinine is further metabolized to trans-3'-hydroxycotinine, the major urinary metabolite of nicotine in tobacco users. It was recently reported that cytochrome P450 2A6 catalyzes the conversion of cotinine to trans-3'-hydroxycotinine. In this work, we report that P450 2A6 metabolizes cotinine not only to trans-3'-hydroxycotinine but also to 5'-hydroxycotinine, norcotinine, and a fourth as yet unidentified metabolite. The products of baculovirus-expressed P450 2A6 [methyl-(3)H]cotinine metabolism were analyzed by radioflow HPLC. Three (3)H-labeled metabolites were detected and were present in approximately equal amounts. The identities of two of the metabolites were confirmed to be 5'-hydroxycotinine and trans-3'-hydroxycotinine by LC/MS/MS and LC/MS analysis and comparison to standards. The third product was not identified. A fourth product of P450 2A6-catalyzed cotinine metabolism was detected by LC/MS. It was identified by cochromatography with a standard and MS and MS/MS data to be norcotinine. An attempt was made to further characterize the unidentified (3)H-labeled metabolite by comparison to the cotinine metabolites generated by hamster liver microsomes. Hamster liver microsomes contain a P450, 2A8, which is closely related to P450 2A6, and have previously been shown to metabolize cotinine to three hydroxylated products, trans-3'-hydroxycotinine, 5'-hydroxycotinine, and N-(hydroxymethyl)norcotinine. We were unable to confirm that N-(hydroxymethyl)norcotinine was the unidentified cotinine metabolite generated by P450 2A6.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409404     DOI: 10.1021/tx990015e

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  11 in total

Review 1.  Polymorphisms of CYP2A6 and its practical consequences.

Authors:  H Raunio; A Rautio; H Gullstén; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

2.  Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.

Authors:  Kannan Rangiah; Wei-Ting Hwang; Clementina Mesaros; Anil Vachani; Ian A Blair
Journal:  Bioanalysis       Date:  2011-04       Impact factor: 2.681

3.  Quantitative analysis of 3'-hydroxynorcotinine in human urine.

Authors:  Pramod Upadhyaya; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2014-10-16       Impact factor: 4.244

4.  CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ion.

Authors:  Linda B von Weymarn; Cassandra Retzlaff; Sharon E Murphy
Journal:  J Pharmacol Exp Ther       Date:  2012-08-06       Impact factor: 4.030

Review 5.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

Review 6.  New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.

Authors:  J Alex Grizzell; Valentina Echeverria
Journal:  Neurochem Res       Date:  2014-06-27       Impact factor: 3.996

7.  Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450BM3 Variant.

Authors:  Inacrist Geronimo; Catherine A Denning; David K Heidary; Edith C Glazer; Christina M Payne
Journal:  Biophys J       Date:  2018-08-27       Impact factor: 4.033

Review 8.  Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism.

Authors:  Yadira X Perez-Paramo; Philip Lazarus
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-12-29       Impact factor: 4.481

Review 9.  Biomarkers of Exposure to Secondhand and Thirdhand Tobacco Smoke: Recent Advances and Future Perspectives.

Authors:  Sònia Torres; Carla Merino; Beatrix Paton; Xavier Correig; Noelia Ramírez
Journal:  Int J Environ Res Public Health       Date:  2018-11-29       Impact factor: 3.390

10.  Evaluation of Serum Cotinine Cut-Off to Distinguish Smokers From Nonsmokers in the Korean Population.

Authors:  Kiwoong Ko; Min Jung Kwon; Song Hyun Yang; Chul Jin Moon; Eun Hee Lee; Hee Yeon Woo; Hyosoon Park
Journal:  Ann Lab Med       Date:  2016-09       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.